Your browser doesn't support javascript.
loading
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire.
Scanlon, Peter H; Nevill, Clareece R; Stratton, Irene M; Maruti, Sonia S; Massó-González, Elvira L; Sivaprasad, Sobha; Bailey, Clare; Ehrlich, Michael; Chong, Victor.
Afiliação
  • Scanlon PH; Gloucestershire Retinal Research Group, Cheltenham General Hospital, Cheltenham, UK.
  • Nevill CR; Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, England.
  • Stratton IM; University of Gloucestershire, Cheltenham, England.
  • Maruti SS; Gloucestershire Retinal Research Group, Cheltenham General Hospital, Cheltenham, UK.
  • Massó-González EL; Gloucestershire Retinal Research Group, Cheltenham General Hospital, Cheltenham, UK.
  • Sivaprasad S; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA.
  • Bailey C; Boehringer Ingelheim International GmBH, Ingelheim, Germany.
  • Ehrlich M; Moorfields Eye Hospital, London, UK.
  • Chong V; Bristol Eye Hospital, Bristol, UK.
Acta Ophthalmol ; 100(2): e560-e570, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34180581
ABSTRACT

PURPOSE:

To estimate prevalence and incidence of diabetic retinopathy (DR) in a UK region by severity between 2012 and 2016 and risk factors for progression to proliferative DR (PDR).

METHODS:

Electronic medical records from people with diabetes (PWD) ≥18 years seen at the Gloucestershire Diabetic Eye Screening Programme (GDESP) and the hospital eye clinic were analysed (HEC). Prevalence and incidence of DR per 100 PWD (%) by calendar year, grade and diabetes type were estimated using log-linear regression. Progression to PDR and associated risk factors were estimated using parametric survival analyses.

RESULTS:

Across the study period, 35 873 PWD had at least one DR assessment. They were aged 66 (56-75) years (median (interquartile range)), 57% male, 5 (1-10) years since diabetes diagnosis, 93% Type 2 diabetes. Prevalence of DR decreased from 38.9% (95% CI 38.1%, 39.8%) in 2012 to 36.6% (95% CI 35.9%, 37.3%) in 2016 (p < 0.001). Incidence of any DR decreased from 10.9% (95% CI 10.4%, 11.5%) in 2013 to 8.5% (95% CI 8.1%, 9.0%) in 2016 (p < 0.001). Prevalence of PDR decreased from 3.5% (95% CI 3.3%, 3.8%) in 2012 to 3.1% (95% CI 2.9%, 3.3%) in 2016 (p = 0.008). Incidence of PDR did not change over time. HbA1c and bilateral moderate-severe NPDR were statistically significant risk factors associated with progression to PDR.

CONCLUSIONS:

Incidence and prevalence of DR decreased between 2012 and 2016 in this well-characterized population of the UK.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinopatia Diabética Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Retinopatia Diabética Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2022 Tipo de documento: Article